← Back to Search

Device

Pelvic Binder for Hemorrhage (PATCH Trial)

N/A
Waitlist Available
Led By Joseph R Hsu, MD
Research Sponsored by Atrium Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to determine whether the use of pelvic binders in the ambulance setting improves outcomes including mortality in patients with pelvic fractures.

Eligible Conditions
  • Hemorrhage
  • Pelvic Fracture
  • Bleeding

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mortality Rate
Secondary study objectives
Length of Stay in Hospital
Number of Participants With Skin Complications After Pelvic Binder Application
Number of Patients With Blood Transfusions
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pelvic BinderExperimental Treatment1 Intervention
Commercially available device used to stabilize the pelvis
Group II: No BinderActive Control1 Intervention
Standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pelvic Binder
2016
N/A
~50

Find a Location

Who is running the clinical trial?

Atrium HealthLead Sponsor
121 Previous Clinical Trials
34,883 Total Patients Enrolled
4 Trials studying Hemorrhage
288 Patients Enrolled for Hemorrhage
Wake Forest University Health SciencesLead Sponsor
1,392 Previous Clinical Trials
2,451,856 Total Patients Enrolled
12 Trials studying Hemorrhage
2,441 Patients Enrolled for Hemorrhage
Joseph R Hsu, MDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
218 Total Patients Enrolled
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top